Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) (PAR-25-374)

GRANT Friday, January 3, 2025- 4:00pm National Institute on Aging Multiple due dates; see announcement. https://grants.nih.gov/grants/guide/pa-files/PAR-25-374.html 08 May 2028

Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) (PA-25-280)

GRANT Friday, January 3, 2025- 4:00pm National Institutes of Health Multiple due dates; see announcement. https://grants.nih.gov/grants/guide/pa-files/PA-25-280.html 08 May 2028

Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional) (RFA-NR-25-003)

GRANT Friday, January 3, 2025- 3:45pm National Institutes of Health Letter of Intent due January 29, 2025. Application due February 28, 2025. https://grants.nih.gov/grants/guide/rfa-files/RFA-NR-25-003.html 01 Mar 2025

Notice of Special Interest (NOSI): Human Cell Biology of Alzheimer's Disease Genetic Variants (NOT-AG-24-039)

GRANT Friday, January 3, 2025- 3:45pm National Institute on Aging Submit applications for this initiative using one of the following notice of funding opportunity (NOFO) or any reissues of these announcements through the expiration date of this notice: PAR-25-3

Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) (PAR-25-331)

GRANT Friday, January 3, 2025- 3:45pm National Institute on Aging The combined budget for direct costs for the two year project period may not exceed $275,000. No more than $200,000 in direct costs may be requested in any single year. Multiple due dates; see an

Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) (PAR-25-332)

GRANT Friday, January 3, 2025- 3:45pm National Institute on Aging, National Institute of Neurological Disorders and Stroke Multiple due dates; see announcement. https://grants.nih.gov/grants/guide/pa-files/PAR-25-332.html 06 Nov 2027

Stanley Satz

Advanced Innovative Partners
United States

Notice of Pre-application Webinar for RFA-AG-25-001, "Deriving Common Data Elements from Real-World Data for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U24 Clinical Trial Not Allowed)" (NOT-AG-24-097)

GRANT Friday, January 3, 2025- 3:30pm National Institute on Aging Pre-application technical assistance webinar. January 8, 2025. 12:30 PM to 1:30 PM Eastern Time. https://grants.nih.gov/grants/guide/notice-files/NOT-AG-24-097.html 09 Jan 2025

Jaishree Capoor

United States

Susan Stocker

, United States

Donghoon Lee

Icahn School of Medicine at Mount Sinai
United States

Fusion: Neuroepigenetics & Neuroepitranscriptomics Conference 4th

CONFERENCE 2025-10-01 00:00:00-2025-10-04 00:00:00 St. Julians, Malta 01 &#x2013 04 October 2025 View Conference Website 0

Clinical Trials on Alzheimer's Disease conference (CTAD) 2025

CONFERENCE 2025-12-01 00:00:00-2025-12-04 00:00:00 San Diego, California 01 &#x2013 04 December 2025 View Conference Website 0

Fusion: Interventions in Aging Conference- 5th

CONFERENCE 2025-10-04 00:00:00-2025-10-07 00:00:00 St. Julians, Malta 04 &#x2013 07 October 2025 View Conference Website 0

John Hardy, Valentina Escott-Price on Pervasive biases in proxy genome-wide association studies based on parental history of Alzheimer's disease.

COMMENT Yes, we agree with these critiques. In fact, when Nature Genetics accepted the proxy “AD” GWAS paper, we wrote saying it had been poorly reviewed (Bellenguez et al., 2022). A better title for the original paper would have been “A Proxy GWAS for Reported D